Article
Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor.
Neuroreport - 1 Jun 1998
Fukudome T, Ohno K, Brengman J M, Engel A G
Abstract excerpt
Quinidine is a long-lived open-channel blocker of the wild-type endplate acetylcholine receptor (AChR). To test the hypothesis that quinidine can normalize the prolonged channel opening events of slow-channel mutants of human AChR, we expressed wild-type AChR and five well characterized slow-channel mutants of AChR in HEK 293 cells and monitored the effects of quinidine on acetylcholine-induced channel currents....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
